CN111773114A - Negative ion crystal eye mask - Google Patents

Negative ion crystal eye mask Download PDF

Info

Publication number
CN111773114A
CN111773114A CN202010695308.8A CN202010695308A CN111773114A CN 111773114 A CN111773114 A CN 111773114A CN 202010695308 A CN202010695308 A CN 202010695308A CN 111773114 A CN111773114 A CN 111773114A
Authority
CN
China
Prior art keywords
eye
eye mask
adhesive film
negative ion
percent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010695308.8A
Other languages
Chinese (zh)
Inventor
张华�
李青山
周学平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Taihua Shouyue Technology Development Co ltd
Original Assignee
Beijing Taihua Shouyue Technology Development Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Taihua Shouyue Technology Development Co ltd filed Critical Beijing Taihua Shouyue Technology Development Co ltd
Priority to CN202010695308.8A priority Critical patent/CN111773114A/en
Publication of CN111773114A publication Critical patent/CN111773114A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/732Starch; Amylose; Amylopectin; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/733Alginic acid; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18

Abstract

An anion crystal eye mask belongs to the fields of material preparation, daily chemical industry, cosmetics, fine chemical industry and the like. The negative ion crystal eye mask consists of two parts, namely an eye mask film and an eye mask liquid. The eye adhesive film is added with natural collagen, natural pearl nano powder and negative ion additive components, so that the effects of activating cells, promoting essence absorption and supplementing collagen required by skin are achieved. The eye patch adhesive film is crescent in shape and can be well attached to an eye curve structure, and in addition, the dense grid on the surface of the eye patch adhesive film is convexly designed, so that a space is provided for fully storing eye patch liquid. The eye patch liquid is added with eye patch essence, anion additive and coconut shell active carbon component. Therefore, the anion crystal eye mask can quickly replenish water and eliminate eye fatigue in a short time, and achieves the effects of reducing edema and relieving eye wrinkles and dark circles.

Description

Negative ion crystal eye mask
Technical Field
The invention belongs to the field of material preparation and daily chemical industry, and particularly relates to an anion crystal eye mask.
Background
The cosmetic market of China gradually enters the maturation stage from the maturation stage, and the skin care products are particularly prominent. Statistics of relevant data show that cream and lotion occupy the main part in the sale of skin care products, and face washing products and bath products are the second place. The mask (eye) market accounts for 1/9 in the skin care product market, about 25 hundred million. With the rise of natural resources in the world, new cosmetic raw materials represented by biological agents, bioactive extracts, natural plant additives and Chinese herbal medicine extracts become the leading direction of product research and development and the mainstream of high-tech symbols.
At present, eye mask on the market is mostly ordinary non-woven fabrics eye mask, and its shortcoming is: the texture is thick and heavy, which can prevent cells from absorbing oxygen and needed nutrients and lose the significance of applying the film; the air bubbles are easy to rise and slide off the face; the material contains fiber, and skin itch can be generated due to static electricity; most essence remains outside and cannot be absorbed sufficiently. In order to solve the above problems and to more effectively develop the effect of an eye mask, it is urgent to develop a novel eye mask.
Disclosure of Invention
In view of the above problems, the present invention provides an anion crystal eye mask, which comprises the following specific schemes:
the negative ion crystal eye mask consists of two parts, namely an eye mask film and eye mask liquid, and is characterized in that:
the eye adhesive film is crescent in shape, dense grid bulges are arranged on the surface of the eye adhesive film, and the eye adhesive film has the function of providing space for fully storing eye adhesive liquid; the eye patch liquid is added with eye patch essence, a negative ion additive and a coconut shell activated carbon component;
the eye adhesive film comprises the following components in percentage by mass: water: 5-10%; natural collagen protein: 35% -50%; natural pearl nano powder: 2% -10%; and (3) negative ion additive: 0% -5%; aqueous gel matrix: 40-50%. The aqueous gel matrix comprises: water, glycerol or propylene glycol with cellulose derivatives, carbomer and alginate, tragacanth, gelatin, starch;
the eye patch liquid comprises the following components in percentage by mass: eye mask essence: 80% -95%; and (3) negative ion additive: 0 to 5 percent; coconut shell activated carbon: 0 to 5 percent. The eye mask essence comprises the following components: deionized water, glycerol, aloe extract, wheat germ oil, lemon oil, mint extract, cellulose gum, sorbitol, 3-iodo-2-propynyl butyl carbamate and a high-molecular humectant.
The anion additive is an additive prepared by specially processing natural ores, has the same pH value as the natural skin pH value, and can stimulate the activity of cells and promote the shedding of aged keratinocytes, thereby reducing the thickness of stratum corneum and accelerating the renewal of cells. The released negative ions can also reduce the damage of ultraviolet rays in sunlight to the skin. In deeper layers of skin, the blood microcirculation system is promoted, the cell metabolism is promoted, and the self regeneration and toxin expelling functions of cells are enhanced.
The coconut shell activated carbon is nano carbon powder and can generate far infrared rays. And the frequency of the generated far infrared ray is consistent with the vibration frequency between molecules and atoms of the living body cell. When far infrared ray acts on skin, the vibration in molecules is increased, cells are activated, the temperature is raised, and blood vessels are expanded; reducing blood viscosity and accelerating blood circulation, particularly microcirculation; timely supplying proper oxygen and nutrients to human organs and tissues to enhance the regeneration capacity of cells; accelerate the excretion of harmful substances in the organism and promote metabolism.
The natural pearl nanopowder can be used for delaying aging, reducing wrinkle, moistening skin, regulating endocrine, eliminating pigmentation such as chloasma and freckle, promoting skin cell metabolism, and enhancing cell regeneration and toxin expelling function.
Compared with the prior art, the invention has the advantages that: the negative ion crystal eye mask can rapidly replenish water and eliminate eye fatigue in a short time by adding the negative ion additive, the natural pearl nano powder and the coconut shell activated carbon into the eye mask film and the eye mask liquid, so that the effects of reducing edema and relieving eye wrinkles and dark circles are achieved, the eye mask film adopts a dense grid convex design, a space is provided for fully storing the eye mask liquid, and the action time of the eye mask film is effectively prolonged.
Drawings
FIG. 1 is a view showing the overall structure of an eye adhesive film;
in the figure: 1-eye adhesive film pasting; 101-dense grid raised.
Detailed Description
The manufacturing process of the eye adhesive film 1 comprises the following steps:
firstly, weighing the aqueous gel matrix according to the weight part of the formula for later use;
secondly, weighing the negative ion additive, the natural pearl nano powder and the collagen according to the weight parts in the formula, adding the mixture into water, and stirring and homogenizing for 2-5 minutes;
thirdly, adding the negative ion additive, the natural pearl nano powder and the collagen which are uniformly stirred in the second step into the aqueous gel matrix weighed in the first step, and stirring and homogenizing for 5-10 minutes to prepare a raw material of the eye adhesive film 1;
and fourthly, adding the raw materials of the eye adhesive film 1 into an eye adhesive film mold which is prepared in advance, cooling to be gelatinous and forming, and taking out.
The preparation process of the eye patch liquid comprises the following steps:
firstly, weighing eye mask essence according to the weight parts of the formula for later use;
and secondly, adding the anion additive and the coconut shell activated carbon into the eye mask essence weighed in the first step according to the weight parts in the formula, and stirring and homogenizing for 5-10 minutes to prepare the eye mask liquid.
The using method comprises the following steps:
firstly, thoroughly cleaning skin around eyes (color cosmetics should be thoroughly removed when makeup is applied around eyes);
secondly, taking out the eye mask, and lightly pasting the eye mask at a position three millimeters below the eyes;
relaxing nerves, standing for about 10-15 minutes, and taking down;
and fourthly, massaging the eye skin by using a point-pressing method until the essence is completely absorbed.
Example 1:
eye adhesive film sticking: water: 5 percent; natural collagen protein: 40 percent; natural pearl nano powder: 2 percent; and (3) negative ion additive: 5 percent; aqueous gel matrix: 48 percent;
eye patch liquid: eye mask essence: 92 percent; and (3) negative ion additive: 3 percent; coconut shell activated carbon: 5 percent.
Example 2:
eye adhesive film sticking: water: 5 percent; natural collagen protein: 40 percent; natural pearl nano powder: 2 percent; and (3) negative ion additive: 0 percent; aqueous gel matrix: 48 percent;
eye patch liquid: eye mask essence: 92 percent; and (3) negative ion additive: 3 percent; coconut shell activated carbon: 5 percent.
Example 3:
eye adhesive film sticking: water: 5 percent; natural collagen protein: 40 percent; natural pearl nano powder: 0 percent; and (3) negative ion additive: 5 percent; aqueous gel matrix: 48 percent;
eye patch liquid: eye mask essence: 92 percent; and (3) negative ion additive: 3 percent; coconut shell activated carbon: 5 percent.
Example 4:
eye adhesive film sticking: water: 5 percent; natural collagen protein: 40 percent; natural pearl nano powder: 2 percent; and (3) negative ion additive: 5 percent; aqueous gel matrix: 48 percent;
eye patch liquid: eye mask essence: 92 percent; and (3) negative ion additive: 0 percent; coconut shell activated carbon: 5 percent.
Example 5:
eye adhesive film sticking: water: 5 percent; natural collagen protein: 40 percent; natural pearl nano powder: 2 percent; and (3) negative ion additive: 5 percent; aqueous gel matrix: 48 percent;
eye patch liquid: eye mask essence: 92 percent; and (3) negative ion additive: 3 percent; coconut shell activated carbon: 0 percent.
Comparative example 1:
eye adhesive film sticking: water: 5 percent; natural collagen protein: 40 percent; natural pearl nano powder: 0 percent; and (3) negative ion additive: 0 percent; aqueous gel matrix: 48 percent;
eye patch liquid: eye mask essence: 92 percent; and (3) negative ion additive: 0 percent; coconut shell activated carbon: 0 percent.
The clinical trial for alleviating eye skin discomfort symptoms of the present invention is as follows:
1. patient receiving criteria:
180 patients with eye fatigue and black eyes for more than one week are collected from 18-65 years old male and female patients, except other serious diseases and medical history, the patients are gathered in 60 patients with periorbital pain, 60 patients with blurred vision and 60 patients with black eyes;
2. treatment grouping: the randomly received patients were divided into six groups of comparative and treatment groups of examples 1, 2, 3, 4, 5, each of which included 30 patients, namely 10 periorbital pain patients, 10 blurred vision patients, and 10 black eye patients;
3. the treatment method comprises the following steps: treatment groups: for patients diagnosed with the above diseases, the crystal eye mask is used as a basic prescription for treatment, the crystal eye mask is used once in the morning and at night every day, a treatment course is 7 days, the patients are diagnosed again, symptoms are compared, side effects are recorded for 8 weeks, other medicines are stopped taking during taking the medicine, and uncooked, cold, spicy and stimulated food is forbidden;
control group: for patients diagnosed with the above diseases, the common eye mask on the market is used for treatment, the common eye mask is used once in the morning and at night every day, 7 days are taken as a treatment course and are used for repeated diagnosis, symptoms are compared, side reactions are recorded for 8 weeks, other medicines are stopped taking during taking, and uncooked, cold, spicy and stimulating foods are forbidden;
4. the evaluation standard of curative effect is as follows: the clinical cure is as follows: the total score of symptoms, decreased by greater than or equal to 90%. The effect is shown: the total score of symptoms is reduced by 70% or more and less than 90%. The method has the following advantages: the total score of symptoms is reduced by greater than or equal to 30% and less than 70%. And (4) invalidation: total integral of symptoms, less than 30%. Note: calculation formula (nimodipine method): (post-treatment score-pre-treatment score)/pre-treatment score 100%;
5. the treatment results are as follows:
the clinical treatment results of the treatment group and the control group are shown in table 1, the overall treatment results of the different symptoms of the treatment group are shown in table 2, and the treatment results of the different symptoms of the control group are shown in table 3:
TABLE 1 clinical treatment results of the treated and control groups
Figure 275244DEST_PATH_IMAGE001
TABLE 2 Overall treatment results for different symptomatic types in the treatment groups
Figure 268608DEST_PATH_IMAGE002
TABLE 3 treatment results for different symptom types in control group
Figure 22938DEST_PATH_IMAGE003
As can be seen from the clinical treatment results of the treatment group and the control group of table 1 above: 150 cases of treatment groups, after 8 weeks of using the eye patch of the invention, the total effective rate of the treatment group of examples 1, 2, 3 and 4 is more than 90%; 30 control groups, the total effective rate of the control group is 70% after taking the eye patch film sold in the market for 8 weeks; therefore, the eye patch provided by the invention has a good effect of relieving eye skin discomfort symptoms and a high cure rate. As can be seen from the overall treatment results for the different symptom types in the treatment groups of table 2: the eye mask is used for treating different symptom types of cases in treatment groups, and after 8 weeks, the total effective rates of periorbital pain, blurred vision and black eye are respectively 90%, 90% and 92%, so that the eye mask has the treatment effect of relieving eye skin discomfort symptoms. According to the data in table 3, the control group adopts the commercially available eye patch for treatment, the periorbital pain, blurred vision and the total effective rate of black eye are respectively 70%, 70% and 70%, and the eye patch disclosed by the invention has good effect and higher cure rate when used for relieving eye skin discomfort symptoms, as can be seen from tables 1 and 2.
In conclusion, the eye mask provided by the invention has a remarkable curative effect on relieving eye skin discomfort symptoms, and is superior to the prior art.

Claims (1)

1. The negative ion crystal eye mask consists of an eye mask adhesive film (1) and eye mask liquid, and is characterized in that:
the eye adhesive film (1) is crescent in shape, and dense grid bulges (101) are arranged on the surface of the eye adhesive film; the eye patch liquid is added with eye patch essence, an anion additive and coconut shell activated carbon components, and comprises the following components in parts by weight:
eye adhesive film sticking: water: 5-10%; natural collagen protein: 35% -50%; natural pearl nano powder: 2% -10%; and (3) negative ion additive: 0% -5%; aqueous gel matrix: 40-50%; the aqueous gel matrix comprises: water, glycerol or propylene glycol with cellulose derivatives, carbomer and alginate, tragacanth, gelatin, starch;
eye patch liquid: eye mask essence: 80% -95%; and (3) negative ion additive: 0 to 5 percent; coconut shell activated carbon: 0% -5%; the eye mask essence comprises the following components: deionized water, glycerol, aloe extract, wheat germ oil, lemon oil, mint extract, cellulose gum, sorbitol, 3-iodo-2-propynyl butyl carbamate and a high-molecular humectant.
CN202010695308.8A 2020-07-19 2020-07-19 Negative ion crystal eye mask Pending CN111773114A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010695308.8A CN111773114A (en) 2020-07-19 2020-07-19 Negative ion crystal eye mask

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010695308.8A CN111773114A (en) 2020-07-19 2020-07-19 Negative ion crystal eye mask

Publications (1)

Publication Number Publication Date
CN111773114A true CN111773114A (en) 2020-10-16

Family

ID=72763087

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010695308.8A Pending CN111773114A (en) 2020-07-19 2020-07-19 Negative ion crystal eye mask

Country Status (1)

Country Link
CN (1) CN111773114A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113143775A (en) * 2021-03-26 2021-07-23 浙江大学 Wrinkle-removing lifting mask matrix or mask and preparation method thereof
CN113925786A (en) * 2021-11-17 2022-01-14 北京顶业工贸有限公司 Silica gel eye patch

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN201185989Y (en) * 2008-04-29 2009-01-28 珠海海狮龙生物科技有限公司 Crystal beauty treatment pad pasting with elastic grid
CN104414870A (en) * 2013-09-07 2015-03-18 巩亚飞 Preparation method of novel vanishing cream

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN201185989Y (en) * 2008-04-29 2009-01-28 珠海海狮龙生物科技有限公司 Crystal beauty treatment pad pasting with elastic grid
CN104414870A (en) * 2013-09-07 2015-03-18 巩亚飞 Preparation method of novel vanishing cream

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
佚名: ""ilisya上网眼贴",获取网址:http://ftba.nmpa.gov.cn:8181/ftban/itownet/hzp_ba/fw/pz.jsp?processid=20150326104729n9gec&nid=20150326104729n9gec", 《国产非特殊用途化妆品备案服务平台》 *
佚名: ""可贝尔眼纹消胶原蛋白水晶眼贴膜",获取网址:http://ftba.nmpa.gov.cn:8181/ftban/itownet/hzp_ba/fw/pz.jsp?processid=20150630090815ug7io&nid=20150630090815ug7io", 《国产非特殊用途化妆品备案服务平台》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113143775A (en) * 2021-03-26 2021-07-23 浙江大学 Wrinkle-removing lifting mask matrix or mask and preparation method thereof
CN113143775B (en) * 2021-03-26 2022-04-19 浙江大学 Wrinkle-removing lifting mask matrix or mask and preparation method thereof
CN113925786A (en) * 2021-11-17 2022-01-14 北京顶业工贸有限公司 Silica gel eye patch

Similar Documents

Publication Publication Date Title
CN106389219A (en) Externally-used traditional Chinese medicine composition with whitening and freckle removing functions and skin-care preparation
CN111773114A (en) Negative ion crystal eye mask
CN107303253A (en) It is a kind of to be used to be damaged renovation agent of skin and preparation method thereof
CN107375032A (en) A kind of composition and preparation method for repairing skin barrier
CN108653129B (en) Skin dressing containing natural plant anti-allergy composition
CN110693745A (en) Hyaluronic acid-containing mask and preparation method thereof
CN113908099A (en) Skin care kit for accelerating skin cutin renewal and preparation method and use method thereof
CN106361617A (en) Eye skin care composition containing Medicago Sativa Seed extractive
CN110604714A (en) Whitening, freckle-removing and anti-aging formula composition and preparation method thereof
KR20190000816A (en) Mask pack with improved elasticity manufactured by using biodegradable polymer and loess, and the method for manufacturing the mask pack
CN111454374A (en) Peach gum extract with skin tightening effect, and preparation method and application thereof
CN110755308A (en) Anti-aging medical biological repair dressing containing traditional Chinese medicines and preparation method thereof
CN114159341B (en) Freeze-dried eye patch and preparation method thereof
CN112587468A (en) Multifunctional multiple-effect eye cream
CN112915100A (en) A composition for preventing and treating scar
CN109646359B (en) Rose-agaric mud membrane paste with effects of cleaning, purifying, maintaining beauty and keeping young and preparation method thereof
CN106038375A (en) Quantum cell proliferation medical skin shining facial mask and preparation method
CN113181071A (en) Eye gel patch
KR20120009183A (en) Composition for promoting the differentiation of human mesenchymal stem cell
CN105902686A (en) In-situ gel eyewash containing nano-carbon crystals and preparation method thereof
CN114053181A (en) Anti-wrinkle composition and application thereof in skin care products
CN110859792A (en) Mask with cell repairing effect and preparation method thereof
CN109745241A (en) A kind of tuckahoe facial mask liquid and preparation method thereof
CN1113668C (en) Chinese-medicinal composition for treating acne, removing spots and beautifying and whitening face
CN102068562A (en) Formula of Chinese medicine for removing ephelis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20201016

WD01 Invention patent application deemed withdrawn after publication